Macquarie Group’s Ultralife ULBI Stock Holding History

Macquarie Group’s Portfolio ULBI Stock Details ULBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-163	Closed	-$1	–	2144
2024 Q1	$1	Buy	+163	New	+$1.33K	﹤0.01%	1883

Other funds holding ULBI

VWA

Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group's ULBI Position: Q2 2024 in Review

Macquarie Group sold out of Ultralife (ULBI) in Q2 2024, closing a stake of 163 shares — an estimated $1 sold.

Macquarie Group first reported a position in ULBI in Q1 2024 and held it in 1 quarter. The position peaked at $1 in Q1 2024. 72 funds tracked by Wall St. Rank hold ULBI as of Q2 2024.

Macquarie Group reported no remaining Ultralife position as of Q2 2024 after selling out during the quarter.
Macquarie Group sold 163 Ultralife shares in Q2 2024, an estimated $1.
Macquarie Group first reported a position in Ultralife in Q1 2024 and held it in 1 quarter.
Macquarie Group's Ultralife position peaked at $1 in Q1 2024.
72 funds tracked by Wall St. Rank held Ultralife as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.